About JSP Pharma
JSP Pharmaceutical Manufacturing (Thailand) PCL., are strong in the business of OEM manufacturing service of Supplement, Pharmaceutical, Herbal and Cosmetics products.
We are capable to produce several categories of dosage form such as Tablet, Capsule, Soft-gelatin capsule, Powder and our latest new categories; Gummy and Chewable soft-gelatin capsule. We do OEM services under keyword “ONE STOP SERVICE”. We do R&D, FDA submission, Artwork design and evaluation, production and then, Delivery.
With rather than 40 years of experience in this business, we can be guaranteed by global standard such as GMP, ISO 9001:2015 and PIC/s.
2022
In June 2022
Board of Director of JSP Pharma agreed to establish new daughter company named “Caresutic Co.,Ltd.” with registered capital at 5,000,000 THB, dividing to Ordinary shares at 50,000 shares, the Par Value was 100 THB per share and JSP has shareholding ratio at 99.99% of paid registered capital. Caresutic Co.,Ltd. is a company who does business about innovation, small cosmetic and dietary supplement manufacturing and Pet supplement manufacturing.
In August 2022
The Extraordinary General meeting of JSP’s shareholders had resolved to approve to amend the purpose of using capital by offering Ordinary shares to Increase capital to public for the first time (IPO). And adding the objective of investment to sub-company about innovation center and small dietary supplement and cosmetic factory and expanding investment by seeking new other business model for extending the business and allocation of the Warrant to Purchase Ordinary Shares of the Company No. 1 not exceeding, 227,500,000 units to allocate to existing shareholders who subscribed without charges by allocation rate at 2 original shares per 1 unit of warrants. The Warrant to Purchase Ordinary Shares has 2 years from the date of issue and the rate of warrants 1 unit per Ordinary shares 1 unit is at 2.50 THB per shares. To increase the registered capital in the amount of not more than 113,750,000 THB from old capital, 227,500,000 THB, dividing to Ordinary shares at 455,000,000 shares, the Par Values was 0.50 THB per share, into the registered capital of 341,250,000 THB, divided to Ordinary Shares at 682,500,000 shares, the Par Value was 0.50 THB per share to support the purpose of allocation of the Warrant to Purchase Ordinary Shares of the Company No. 1.
In September 2022
We changed the initials of registered in Listing Securities from “JP” to “JSP”.
Caresutic Co.,Ltd., sub-company of JSP Pharma, increased the registered capital at 25,000,000 THB from old capital, 5,000,000 THB by dividing into Ordinary Shares at 50,000 shares, the Par Value was 100 THB per share into 30,000,000 THB registered capital, dividing into Ordinary Shares at 300,000 shares, the Par Value was 100 THB per share. By the additional 250,000 shares, the Par value was 100 THB per share, we shared the increased Ordinary Shares by not change any proportion of shareholders.
In December 2022
We expanded the capacity of pharmaceutical production in Bangkok completely. The capacity of production had reached to 20 – 25 million bottles per year.
2021
In May 2021
The Extraordinary General meeting of JSP’s shareholders resolved to approve to register JSP company to MAI of stock exchange of Thailand by decreasing unpaid registered capital from 213,000,000 THB, dividing to Ordinary Shares at 426,000,000 Shares, the Par Value was at 0.50 THB per share, to 170,000,000 THB, dividing to Ordinary Shares at 340,000,000 Shares, the Par Value was at 0.50 THB per share. Then, JSP’s shareholders resolved to approve to increase the registered capital from 170,000 THB, dividing to Ordinary Shares at 340,000,000 Shares, the Par Value was 0.50 THB per share, to 227,500,000 THB, dividing to Ordinary Shares at 455,000,000 Shares, the Par Value was 0.50 THB per share. The total of registered capital was 57,500,000 THB. This new capital was offered to Ordinary shares to Increase capital to public for the first time (IPO) or calculated as 25.27% of after IPO paid registered capital.
In September 2021
The Extraordinary General meeting of JSP’s shareholders resolved to approve about the criteria for the allocation of new Ordinary shares for sales to the public for the first time (IPO). The approved offering of Ordinary Shares was not more than 113,750,000 shares for IPO and not more than 1,250,000 shares for board of director and employees of JSP Pharma.
In October 2021
We offered the Ordinary Share to public for the first time (IPO) and registered the paid-up capital with Department of Business Development, Ministry of Commerce on October 28th, 2021.
In November 2021
JSP Pharma began to purchase MAI of Stock Exchange of Thailand on November 2nd, 2021.
2020
In March 2020
JSP had offered to sell Right Offering to “The Trust” , the venture capital business for SME KaoKaiPaiduaygun 1 and HIP Holding 4 Co., Ltd., the sub-company of The Trust, was at 20,000,000 shares which were higher fair value than the independent financial advisor.
In November 2020
The Extraordinary General Meeting of JSP’s shareholders, No. 2/ 2020, resolved to approve to register to MAI of Stock Exchange of Thailand under these conditions;
- To approve to increase the registered capital for selling Initial Public Offering (IPO) at 43,000,000 THB, from old registered capital, 170,000,000 THB to new registered capital, 213,000,000 THB, dividing to Ordinary Shares at 86,000,000 shares, the Par value was 0.50 THB per share.
- To approve to manage Ordinary Shares of company at 86,000,000 shares, the Par Value was 0.50 THB per share, to do Initial Public Offering (IPO) or calculated as 21.9% of total paid-up registered capital after IPO.
2019
In 2019
The 2019 Annual Extraordinary General Meeting had resolved to approve to increase the registered capital from 130,000,000 THB to 170,000,000 THB by offering the Right Offering at 80,000,000 shares for using as Working Capital which has allocated and offered to Supap Group Co.,Ltd at 60,000,000 shares, the Par Value was 0.50 THB per share in July 2019.
2018
In 2018
The Extraordinary General Meeting had resolved to approve to transform the company into Public Company Limited. And changed the Par Value from 100 THB per share to 0.50 THB per share. After the change, the total of Ordinary Share of company was 260,000,000 shares, the Par Value was 0.50 THB per share.
2017
In 2017
We changed company structure of company group by gathering COX Laboratory LTD., PART which were Business Combination Under Common Control. Because in that time, Daengprasert Family was major holders.
2016
We built new factory at 260, Sribuaban sub-district, Muang Lamphun district, Lamphun Province, Thailand 51000 to increase the capacity of Traditional Medicine and Herbal product production.
2015
2015
We increased the registered capital from 46,000,000 THB to 66,000,000 THB by offering shares to old shareholder for using as Working Capital.
2014
In January 2014
We increased the registered capital from 1,000,000 THB to 16,000,000 THB by offering shares to old shareholder for using as Working Capital.
In June 2014
We increased the registered capital from 16,000,000 THB to 46,000,000 THB by offering shares to old shareholder for using as Working Capital.
2013
In November 2014
On November 15th, 2014, we established the company in the named “JSP Pharmaceutical Manufactory (Thailand) CO.,LTD.” with the registered capital at 1,000,000 THB, dividing into Ordinary Share at 10,000 shares, the Par Value was 100 THB per share. The factory is located at 255, 257 Soi. Sathupradit 58, Bangpongpang Sub-district, Yannawa District, Bangkok, Thailand 10120